Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future

Henriqueta Louro1,2, Milla Heinälä3, Jos Bessems4, Jurgen Buekers4, Theo Vermeire5, Marjolijn Woutersen5, Jacqueline van Engelen5, Teresa Borges6, Christophe Rousselle7, Eva Ougier7, Paula Alvito1,8, Carla Martins1,8,9, Ricardo Assunção1,8, Maria João Silva1,2, Anjoeka Pronk10, Bernice Schaddelee-Scholten10, Maria Del Carmen Gonzalez11, Mercedes de Alba11, Argelia Castaño11, Susana Viegas12,9
1INSA - National Institute of Health Dr. Ricardo Jorge, Portugal
2ToxOmics – Centre for Toxicogenomics and Human Health, Nova Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Portugal
3FIOH - Finnish Institute of Occupational Health, Finland
4VITO - Flemish Institute for Technological Research, Belgium
5RIVM - National Institute for Public Health and the Environment, the Netherlands
6DGS - Directorate-General of Health, Ministry of Health, Portugal
7ANSES - Agency for Food, Environmental and Occupational Health & Safety, France
8CESAM-Centre for Environmental and Marine Studies, University of Aveiro, Aveiro, Portugal
9Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Portugal
10TNO - Organization for Applied Scientific Research, the Netherlands
11ISCIII- - Instituto de Salud Carlos III, Spain
12H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Portugal

Tài liệu tham khảo

Angerer, 2011, Human biomonitoring assessment values: approaches and data requirements, Int. J. Hyg Environ. Health, 214, 348, 10.1016/j.ijheh.2011.06.002 Apel, 2017, New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission, Int. J. Hyg Environ. Health, 220, 152, 10.1016/j.ijheh.2016.09.007 Boogaard, 2011, Human biomonitoring as a pragmatic tool to support health risk management of chemicals–examples under the EU REACH programme, Regul. Toxicol. Pharmacol., 59, 125, 10.1016/j.yrtph.2010.09.015 Cherrie, 2006, How important is inadvertent ingestion of hazardous substances at work?, Ann. Occup. Hyg. Choi, 2017, Identification of exposure to environmental chemicals in children and older adults using human biomonitoring data sorted by age: results from a literature review, Int. J. Hyg Environ. Health, 220, 282, 10.1016/j.ijheh.2016.12.006 EC ECHA ECHA, 2015 ECHA, 2015 ECHA, 2014 ECHA, 2012 EFSA, 2017 EFSA EFSA, 2012, Risk assessment of contaminants in food and feed, EFSA J., 10, s1004, 10.2903/j.efsa.2012.s1004 EFSA, 2010, Scientific opinion on lead in food, EFSA J., 8 EFSA, 2009, Guidance of the Scientific Committee on Use of the benchmark dose approach in risk assessment, EFSA J., 7 European Commission, 2013 European Commission, 2002 FAO/WHO, 2009 FAO, 2013, Guidelines on the application of RA for feed, CAC/GL, 80 Ganzleben, 2017, Human biomonitoring as a tool to support chemicals regulation in the European Union, Int. J. Hyg Environ. Health, 220, 94, 10.1016/j.ijheh.2017.01.007 Grandjean, 2012, Strengths and limitations of HBM – imprecision matters, Int. J. Hyg Environ. Health, 215, 94, 10.1016/j.ijheh.2011.11.008 Hays, 2009, Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context, J. Appl. Toxicol., 29, 275, 10.1002/jat.1410 Knutsen, 2018, Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food, EFSA J., 16 Koch, 2017, Phthalate metabolites in 24-h urine samples of the German Environmental Specimen Bank (ESB) from 1988 to 2015 and a comparison with US NHANES data from 1999 to 2012, Int. J. Hyg Environ. Health, 220, 130, 10.1016/j.ijheh.2016.11.003 Meek, 2011, Risk assessment of combined exposure to multiple chemicals: a WHO/IPCS framework, Regul. Toxicol. Pharmacol., 60, S1, 10.1016/j.yrtph.2011.03.010 RPA - Risk & Policy Analysts Limited, 2017 SCCS, 2015 SCCS, 2018 Schulte, 1999, Using molecular epidemiology in assessing exposure for risk assessment, Ann. N. Y. Acad. Sci., 895, 101, 10.1111/j.1749-6632.1999.tb08079.x SCOEL, 2017 SCOEL, 2014 St-Amand, 2014, Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context, Toxicol Lett., 231, 126, 10.1016/j.toxlet.2014.10.019 UBA USNAS, 2017 WHO/IPCS, 2009 WHO/IPCS, 2009 WHO/IPCS, 2001 WHO/IPCS, 2000, United Nations environment programme, Environ. Health Criter., 214, 6 WHO/IPCS, 1993 WHO/IPCS, 2010 Zidek, 2017, A review of human biomonitoring data used in regulatory risk assessment under Canada's Chemicals Management Program, Int J Hyg Environ Health, 220, 167, 10.1016/j.ijheh.2016.10.007 WHO, 2010